LATOYA HOWARD: Open Payments
NPI 1649843160 · NATCHITOCHES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$316 in 14 payments from 10 companies in 2025. Trend: 2023 $1,198 · 2024 $984 · 2025 $316
Food & beverage: $316
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $93 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| Astellas Pharma US Inc | 2 | $37 |
| Daiichi Sankyo Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
| BeiGene USA, Inc. | 1 | $19 |
| Stemline Therapeutics Inc. | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| EMD Serono, Inc. | 1 | $16 |
Products named: Fabhalta, KEYTRUDA, Vyloy, Enhertu, INGREZZA, BRUKINSA, Orserdu, XPOVIO.
Industry payments across LA — which companies pay providers there.
